DrugPatentWatch Database Preview
Profile for New Zealand Patent: 579802
US Patent Family Members and Approved Drugs for New Zealand Patent: 579802
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Sep 3, 2029 | Bristol-myers Squibb | EVOTAZ | atazanavir sulfate; cobicistat |
➤ Sign Up | Sep 3, 2029 | Gilead Sciences Inc | GENVOYA | cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate |
➤ Sign Up | Sep 3, 2029 | Janssen Prods | PREZCOBIX | cobicistat; darunavir ethanolate |
➤ Sign Up | Sep 3, 2029 | Gilead Sciences Inc | STRIBILD | cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |